Oleksandr Petrenko

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Corrigendum to: 'Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk' [JHEP Reports (2026) 19;8(9):101932].

Corrigendum to: 'Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk' [JHEP Reports (2026) 19;8(9):101932].

Journal: JHEP reports : innovation in hepatology

Published: September 03, 2026

Characterization of liver disease regression in murine models of liver fibrosis and portal hypertension.

Characterization of liver disease regression in murine models of liver fibrosis and portal hypertension.

Journal: Scientific reports

Published: January 17, 2026

Adult-Onset Still's Disease Presenting with Atypical Kikuchi-Fujimoto Disease-Like Histiocytic Necrotizing Lymphadenitis: A Diagnostic Pitfall.

Adult-Onset Still's Disease Presenting with Atypical Kikuchi-Fujimoto Disease-Like Histiocytic Necrotizing Lymphadenitis: A Diagnostic Pitfall.

Journal: European journal of case reports in internal medicine

Published: December 06, 2025

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Journal: Journal for immunotherapy of cancer

Published: August 31, 2025

Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk.

Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk.

Journal: JHEP reports : innovation in hepatology

Published: August 21, 2025

Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk.

Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk.

Journal: JHEP reports : innovation in hepatology

Published: August 21, 2025

Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease.

Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease.

Journal: JHEP reports : innovation in hepatology

Published: July 04, 2025

Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models.

Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models.

Journal: Scientific reports

Published: January 14, 2025

Crosstalk between CD8+ T cells and systemic bile acid metabolism shapes antiviral immunity and immunopathology.

Crosstalk between CD8+ T cells and systemic bile acid metabolism shapes antiviral immunity and immunopathology.

Journal: JCI insight

Published: December 03, 2024

Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization.

Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 31, 2024

Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis.

Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 18, 2024

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 09, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026